US Patent 11566079 Subcutaneous formulations of anti-CD38 antibodies and their uses
Patent 11566079 was granted and assigned to Janssen Biotech on January, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11566079 Subcutaneous formulations of anti-CD38 antibodies and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
